LifeStance Health Group (NASDAQ:LFST) Coverage Initiated by Analysts at KeyCorp

KeyCorp initiated coverage on shares of LifeStance Health Group (NASDAQ:LFST) in a research note published on Tuesday morning, Marketbeat Ratings reports. The brokerage issued an overweight rating and a $9.00 price target on the stock.

Several other equities research analysts have also commented on the company. Canaccord Genuity Group assumed coverage on LifeStance Health Group in a research report on Thursday, April 3rd. They set a “buy” rating and a $8.00 target price on the stock. The Goldman Sachs Group upgraded LifeStance Health Group from a “neutral” rating to a “buy” rating and set a $10.00 price target on the stock in a report on Monday, December 16th. Finally, William Blair reiterated an “outperform” rating on shares of LifeStance Health Group in a research note on Friday, February 28th. One investment analyst has rated the stock with a sell rating, one has assigned a hold rating and five have issued a buy rating to the company. According to MarketBeat.com, the stock has an average rating of “Moderate Buy” and a consensus price target of $8.58.

LifeStance Health Group Price Performance

Shares of NASDAQ LFST opened at $6.53 on Tuesday. The company has a quick ratio of 1.32, a current ratio of 1.32 and a debt-to-equity ratio of 0.19. The company has a market capitalization of $2.51 billion, a PE ratio of -25.12 and a beta of 1.30. The firm has a fifty day simple moving average of $7.37 and a 200 day simple moving average of $7.34. LifeStance Health Group has a twelve month low of $4.64 and a twelve month high of $8.61.

Insider Transactions at LifeStance Health Group

In related news, insider Lisa K. Miller sold 18,845 shares of LifeStance Health Group stock in a transaction on Monday, March 17th. The shares were sold at an average price of $6.90, for a total value of $130,030.50. Following the completion of the sale, the insider now owns 339,810 shares of the company’s stock, valued at approximately $2,344,689. This trade represents a 5.25 % decrease in their position. The transaction was disclosed in a document filed with the SEC, which can be accessed through the SEC website. 6.60% of the stock is owned by insiders.

Institutional Inflows and Outflows

A number of large investors have recently made changes to their positions in LFST. Blue Trust Inc. increased its position in shares of LifeStance Health Group by 124.4% during the fourth quarter. Blue Trust Inc. now owns 3,828 shares of the company’s stock worth $27,000 after acquiring an additional 2,122 shares in the last quarter. LPL Financial LLC increased its holdings in LifeStance Health Group by 6.0% during the 4th quarter. LPL Financial LLC now owns 37,584 shares of the company’s stock worth $277,000 after purchasing an additional 2,127 shares in the last quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. raised its stake in shares of LifeStance Health Group by 2.4% in the fourth quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 138,781 shares of the company’s stock worth $1,023,000 after purchasing an additional 3,305 shares during the last quarter. MetLife Investment Management LLC lifted its holdings in shares of LifeStance Health Group by 6.8% in the fourth quarter. MetLife Investment Management LLC now owns 85,914 shares of the company’s stock valued at $633,000 after purchasing an additional 5,492 shares in the last quarter. Finally, Zurcher Kantonalbank Zurich Cantonalbank boosted its position in shares of LifeStance Health Group by 31.4% during the third quarter. Zurcher Kantonalbank Zurich Cantonalbank now owns 24,105 shares of the company’s stock valued at $169,000 after buying an additional 5,767 shares during the last quarter. 85.50% of the stock is owned by institutional investors.

About LifeStance Health Group

LifeStance Health Group, Inc, through its subsidiaries, provides outpatient mental health services to children, adolescents, adults, and geriatrics in the United States. The company offers patients a suite of mental health services, including psychiatric evaluations and treatment, psychological, and neuropsychological testing, as well as individual, family, and group therapy.